CLINICAL_TRIALS
trial_result
· 2013-12-06
Clinical Trial Update: A Study of Degarelix in Taiwanese Patients With Prostate Cancer [Phase 3]
Summary
Phase 3 clinical trial evaluating degarelix in Taiwanese patients with prostate cancer has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-12-06